The apoptogenic effect of p-coumaric acid, a phenolic acid found in various edible plants, on human acute leukemia Jurkat T cells was investigated. Exposure of Jurkat T cells to p-coumaric acid (50-150 μM) caused cytotoxicity and TdT-mediated dUTP nick-end labeling (TUNEL)-positive apoptotic DNA fragmentation along with Bak activation, Δψm loss, activation of caspase-9, -3, -7, and -8, and PARP degradation in a dose-dependent manner. However,these apoptotic events were completely abrogated in Jurkat T cells overexpressing Bcl-2.Under these conditions, necrosis was not accompanied.
Introduction
Apoptosis is the process of programmed cell death that can be triggered by a variety of pathological and physiological stimuli. Morphologically, it is characterized by cell shrinkage, chromatin condensation, membrane blebbing, chromosomal DNA fragmentation and forming membrane-bound apoptotic bodies [12] . While apoptosis is known to play an important role in the regulation of homeostasis in multicellular organism, an imbalance between cell proliferation and apoptotic cell death may cause tumor formation [28] . In addition, apoptotic cell death has been proposed as an efficient mechanism by which malignant tumor cells can be removed upon treatment with chemotherapeutic drugs, in that the induction of apoptosis in tumor cells results in their own destruction into apoptotic bodies which can be cleared by surrounding cells without accompanying a local damaging inflammatory response [13] . Diverse cytotoxic approaches including anticancer drugs, ionizing radiation, immunotherapy, and suicide gene therapy, which are currently used for treatment of tumor cells, are known to be predominantly mediated through triggering apoptosis program [17] . However, all these cytotoxic treatments often have significant limitations due to their side effects on normal cells and tissues [13] . In this context, the development of pharmacologically safe anticancer agents, whose apoptogenic activity can be more confined to tumor cells rather than normal cells, has been required.
Hydroxycinnamic acids, including p-coumaric, caffeic, ferulic, and sinapic acids, are a major class of phenolic compounds found in edible plants and their products such as cereals, coffee, peanuts, fruits, and vegetables [29, 34] . Whereas hydroxycinnamic acids are usually found as esters of either glycosides or organic acid, or are bound to protein and other cell wall polymers, only a small number of them are found as free acids in nature [14] . In addition, hydroxycinnamic acids are known to possess a number of im-portant health benefits [3, 4, 15, 25, 33] . In particular, it has been shown that p-coumaric acid can exert various beneficial effects which include antioxidation [9] , antimicrobial activity [36] , cancer chemoprevention with inhibiting cancer cell growth [16] , and antimelanogenesis [2] . However, little is known about the mechanism responsible for the antitumor activity of p-coumaric acid.
In the present study, we have investigated whether the cytotoxicity of p-coumaric acid toward human acute leukemia Jurkat T cells is attributable to induction of apoptotic cell death. To elucidate the apoptotic mechanism, p-coumaric acid-induced apoptotic events of Jurkat T cells transfected with the vector (JT/Neo) have been compared with those of Jurkat T cells transfected with the Bcl-2 gene (JT/Bcl-2). The inhibitory effects of the pan-caspase-inhibitor z-VADfmk on p-coumaric acid-induced apoptotic cell death have also been analyzed. The results show that p-coumaric acid induces apoptosis of Jurkat T cells through Bak activation, mitochondrial damages, leading to mitochondrial membrane potential (Δψm) loss and subsequent activation of caspase cascade including caspase-9, -3, -7, and -8, which can be blocked by overexpression of Bcl-2. As compared with malignant Jurkat T cells, normal human T cells appear to be more refractory to the apoptogenic activity of p-coumaric acid.
Materials and Methods
Reagents, antibodies, cells, and culture medium The ECL Western blotting kit was purchased from Amersham (Arlington Heights, IL, USA), and Immobilon-P membrane was obtained from Millipore Corporation (Bedford, MA, USA). Anti-cytochrome c was purchased from Pharmingen (San Diego, CA, USA), and anti-caspase-3, anti-Bid, anti-poly (ADP-ribose) polymerase (PARP), anti-Bid, ant-Bax, anti-Bcl-2, anti-Bcl-xL, and anti-β-actin were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti-caspase-8, and anti-caspase-9, anti-caspase-7, anti-Bad, and anti-Bid were from Cell Signaling (Beverly, MA, USA). Anti-Bak (Ab-1) and anti-Bax (6A7) were obtained from Calbiochem (San Diego, CA, USA). p-Coumaric acid, phytohemagglutinin A (PHA), and 3,3'dihexyloxacarbocyanine iodide (DiOC6) were purchased from Sigma (St. Louis, MO, USA). The broad-range caspase inhibitor z-VAD-fmk was obtained from Calbiochem (San Diego, CA, USA). Annexin V-FITC apoptosis kit was purchased from Clontech (Takara Bio Inc., Shiga, Japan). FADD-positive wild-type Jurkat T cell clone A3, FADD-deficient Jurkat T cell clone I2.1, and capas-8-deficient Jurkat T cell clone I9.2 were purchased from ATCC (Manassas, VA, USA). Jurkat T cell clone transfected with vector (JT/Neo), and Jurkat T cell clone transfected with Bcl-2 gene (JT/Bcl-2) were used in this experiment. Jurkat T cells and human peripheral T cells were maintained in RPMI 1640 (Hyclone, Gaithersburg, MD, USA) containing 10% fetal bovine serum, 20 mM HEPES (pH 7.2), 5×10
-5 M β-mercaptoethanol, and 100 μg/ml gentamycin. For the culture of both JT/Neo and JT/Bcl-2 cells, G418 (A.G. Scientific Inc., San Diego, CA, USA) was added to the RPMI 1640 medium at a concentration of 200 μg/ml.
Cytotoxicity assay
The cytotoxic effect of p-coumaric acid on Jurkat T cell was analyzed by MTT assay reflecting the cell viability as previously described [19] . For MTT assay, Jurkat T cells transfected with vector JT/Neo or Bcl-2 gene (5×10 4 /well) were added to serial dilutions of p-coumaric acid in 96-well plates. At 63 hr after incubation, 50 μg of MTT solution (1.1 mg/ml) was added to each well and incubated for an additional 4 hr. After centrifugation, the supernatant was removed from each well and then 150 μl of DMSO was added to dissolve the colored formazan crystal produced from MTT. OD values of the solutions were measured at 540 nm by a plate reader.
TdT-mediated dUTP nick-end labeling (TUNEL) assay Jurkat T cells treated with apigeninidin were adhered onto glass cover slips pretreated with 2% aminopropyltriethoxysilane for 30 min in a humidified chamber as previously described [21] . The cells were then subjected to fluorescence-terminal dUTP nick-end labeling (TUNEL) using an In Situ Cell Death Detection Kit (Roche). Thereafter, the cells were mounted with propidium iodide (PI) on slides to label nuclei and then examined under a confocal laser scanning microscope.
Flow cytometric analysis Cell cycle progression of Jurkat T cells following exposure to p-coumaric acid was analyzed by flow cytometry as described elsewhere [18] . The extent of necrosis was detected with an Annexin V-FITC apoptosis kit (Clontech, Takara Bio Inc., Shiga, Japan). The cells (5×10 p-Coumaric acid-induced alteration in the mitochondrial membrane potential (Δψm) was measured by flow cytometry after cells were stained with 50 nM 3,3'dihexyloxacarbocyanine iodide (DiOC6) for 15 min at 37°C as previously described [43] . Activation of Bak and Bax following treatment with p-coumaric acid was measured by flow cytometry as previously described [35] . Briefly, cells ( 1×10 6 ) were washed with PBS and fixed in PBS/1.0% paraformaldehyde on ice for 30 min. Cells were then washed three times in PBS/1% FBS. Staining with conformation-specific antibodies against Bak (Ab-1) and Bax (6A7) was performed with a proper dilution of individual antibodies in 100 μl staining buffer (PBS, 500 μg/ml digitonin). Then, cells were washed and resuspended in 100 μl staining buffer containing Alexafluor 488-labeled goat anti-mouse IgG. The conformational changes of Bak and Bax were measured by flow cytometry.
Preparation of cell lysates and Western blot analysis
The cell lysates were prepared by suspending 5×10 6 Jurkat T cell in 250 μl of lysis buffer (137 mM NaCl, 15 mM EGTA, 1 mM sodium orthovanadate, 15 mM MgCl2, 0.1% Triton X-100, 25 mM MOPS, 5.0 μg/ml proteinase inhibitor E-64, and pH 7.2). The cells were disrupted by sonication and extracted at 4 o C for 30 min. An equivalent amount of protein lysate (20-30 μg) was denatured with SDS sample buffer, and subjected to electrophoresis on a 10% SDS gradient polyacrylamide gel with MOPS buffer. The proteins were electrotransferred to Immobilon-P membranes and then probed with individual antibodies. Detection of each protein was carried out with and ECL Western blotting kit according to the manufacturer's instructions. Previous studies have demonstrated that cytochrome c release from mitochondria and subsequent activation of caspase cascade are often involved in chemotherapeutic agent-induced apoptotic signaling pathway [27, 37] . It has also been demonstrated that anti-apoptotic protein Bcl-2 can protect cells from apoptotic cell death induced by diverse stimuli including chemotherapeutic agents, via blocking mitochondrial damage which leads to mitochondrial membrane potential (Δψm) loss and cytochrome c release [22, 42] . To examine whether apoptotic cell death is involved in the cytotoxicity of p-coumaric acid, in this context, we decided to compare the cytotoxic effect of p-coumaric acid on JT/Neo and JT/Bcl-2 cells. When JT/Neo cells were treated with p-coumaric acid (50-150 μM) for 60 hr, the cell viability, which was determined by MTT assay, appeared to decline significantly in a dose-dependent manner (Fig. 1B) . Although the viability of JT/Neo cells was not affected upon treatment with 50 μM p-coumaric acid, the cell viabilities declined to the levels of 85.4% and 43.0% following exposure to p-coumaric acid at concentrations of 100 μM and 150 μM, respectively. Under these conditions, however, p-coumaric acid-induced cytotoxicity was significantly reduced in JT/Bcl-2 cells overexpressing Bcl-2, demonstrating suppressive effect of Bcl-2 on the cytotoxicity of p-coumaric acid.
Since current results raised the possibility that the apoptotic cell death, which is sensitive to the anti-apoptotic action of Bcl-2, was mainly attributable to the cytotoxicity of p-coumaric acid, we further investigated whether the apoptotic DNA fragmentation was induced in JT/Neo cells following ex- (Fig. 2B ). Under these conditions, while the apoptotic changes appeared to be more apparent when the cells were treated with 150 μM than with 100 μM p-coumaric acid, the necrotic cells stained only with PI were barely detected. The levels of neither (Fig. 3A) . This demonstrated that p-coumaric acid (100-150 μM) could disrupt Δψm in a dose-dependent manner. At the same time, however, p-coumaric acid failed to disrupt Δψm in JT/Bcl-2 cells. Since Δψ m loss is known to be one of the initial intracellular changes that are accompanied by apoptotic cell death [40, 41] , these results suggested that Δψm disruption was associated with p-coumaric acid-induced apoptosis in JT/Neo cells. These results also indicated that the Δψm loss was mediated by a conserved apoptogenic mechanism, which could be targeted by the anti-apoptotic role of Bcl-2.
Since several studies have reported that Δψm loss precedes the release of cytochrome c release into the cytosol, leading to activation of capase-9 and -3 [23, 24, 39] , it was likely that Δψm loss and subsequent induction of mitochondria-dependent caspase cascade activation, which could be blocked by overexpression of Bcl-2, might play an essential role in p-coumaric acid-induced apoptosis of Jurkat T cells.
To test this prediction, it was investigated in both JT/Neo and JT/Bcl-2 cells, by Western blot analysis, whether the induced apoptosis by p-coumaric acid was accompanied by mitochondrial cytochrome c release and subsequent activation of caspase cascade. In accordance with the Δψm loss, the caspase-9 activation that proceeded through proteolytic cleavage of inactive proenzyme (47 kDa) to active forms (37/35 kDa) was detected (Fig. 3B) . The cleavage of procaspase-3 (32 kDa) into active form (17 kDa) as well as the cleavage of procaspase-7 (35 kDa) into active form (20 kDa) was also detected. The activation of caspase-8 through proteolytic cleavage of proenzyme (57 kDa) into active forms (43/41 kDa) was significantly enhanced. In JT/Neo cells after treatment with p-coumaric acid, the PARP degradation was detected along with the activation of caspase-3. However, these apoptotic events were completely abrogated in JT/Bcl-2 cells.
Previously, it has been reported that the pro-apoptotic multidomain Bcl-2 family members (Bax and Bak) mediate permeabilization of the mitochondrial outer membrane (MOM), whereas anti-apoptotic Bcl-2 family members (Bcl-2, Bcl-xL and Mcl-1) prevent cytochrome c efflux triggered by Bak or Bax via either directly or inactivating the BH3-only pro-apoptotic Bcl-2 family members (Bad, Bid, Bim and Puma) [5, 8] . It has also been shown that alteration in the expression ratio of Bak to Bcl-2 and/or Bax to Bcl-2, resulting in an enhancement in the ratio of Bak to Bcl-2 and/or Bax to Bcl-2, is often required for provoking the activation of Bak and/or Bax during the mitochondria damage-mediated apoptotic cell death induced by chemotherapeutic agents [1, 5, 7, 11] . To examine the upstream pro-apoptotic events that mediate p-coumaric acid-induced Δψm loss, the expression levels of Bcl-2 family proteins, such as the pro-apoptotic Bcl-2 family members (Bad, Bak, Bax and Bid) and the anti-apoptotic Bcl-2 family members (Bcl-2 and Bcl-xL), were compared by Western blot analysis between JT/Neo and JT/Bcl-2 cells after treatment with p-coumaric acid. As shown in Fig. 3C , the expression level of pro-apoptotic multidomain Bcl-2 family member Bak was enhanced in JT/Neo and JT/Bcl-2 cells following exposure to p-coumaric acid, whereas those of Bad, Bax, Bcl-2, and Bcl-xL remained constant in both cells. In addition, the level of Bid protein (22 kDa), which was previously cleaved by active caspase-8 to generate the truncated Bid (tBid, 15 kDa) causing Δψm loss [26] , appeared to slightly decline in JT/Neo cells treated with 150 μM p-coumaric acid, whereas this apoptotic change was completely abrogated in JT/Bcl-2 cells. These results suggested that the upregulation of in the level of Bak might be associated with p-coumaric acid-mediated disruption of Δψm loss, possibly via causing the activation of Bak. In order to confirm that the p-coumaric acid-induced apoptosis is accompanied by the activation of pro-apoptotic multidomain Bcl-2 family members (Bak and Bax), which is known to be upstream of Δψm loss [5] [6] [7] , the activation of Bak and Bax in JT/Neo and JT/Bcl-2 cells treated with 150 μM p-coumaric acid was analyzed by flow cytometry using the conformation-specific anti-Bak (Ab-1) or anti-Bax (6A7). As shown in Fig. 3D , the activation of Bak was detected in JT/Neo cells, but not in JT/Bcl-2 cells overexpressing Bcl-2. Under the same conditions, the activation of Bax was not observed in JT/Neo and JT/Bcl-2 cells (data not shown). In order to examine whether the activation of caspase cascade was critical for p-coumaric acid-induced apoptosis, we investigated the effect of the pan-caspase inhibitor (z-VAD-fmk) [38] on p-coumaric acid-induced apoptotic events in JT/Neo cells. After JT/Neo cells were pretreated with z-VAD-fmk for 2 hr, the cells were exposed to 150 μM p-coumaric acid for 48 hr. Although the apoptotic sub-G1 peak was barely detectable in continuously growing JT/Neo cells, it increased to the level of 28.6% in the presence of 150 μM p-coumaric acid for 48 hr (Fig. 4A) . The p-coumaric acid-induced sub-G1 peak was diminished to the basal level by pretreatment with z-VAD-fmk, whereas the p-coumaric acid-induced Δψm loss was not abrogated by z-VAD-fmk (Fig. 4B) . These results demonstrated that the Δψm loss was an upstream event of the caspase cascade activation which was a prerequisite for p-coumaric acid-induced apoptotic cell death. Consequently, current results indicated that p-coumaric acid-induced apoptosis was mediated by Bak activation, Δψm loss, and subsequent activation of multiple caspases including caspase-9, -3, -7 and -8, leading to PARP degradation, which could be blocked by Bcl-2. As a potential mechanism underlying the apoptosis provoked by antineoplastic drugs, upregulation of FasL and/or Fas expression has been implicated [10, 30, 31] . In order to further examine an involvement of Fas/FasL system in p-coumaric acid-induced apoptosis, we compared cytotoxic effect of p-coumaric acid on FADD-and caspase-8-positive wild-type Jurkat T cells (clone A3) with that on FADD-deficient Jurkat T cells (clone I2.1) and caspase-8-deficient Jurkat T cells (clone I9.2), both of which were previously refractory to Fas-mediated apoptosis [20] . As shown in Fig. 5 , irrespective of the FADD deficiency, these Jurkat T cell clones exhibited essentially similar sensitivity to the cytotoxicity of p-coumaric acid. These results confirmed that the p-coumaric acid-induced apoptosis of Jurkat T cells was not provoked by the interaction of Fas with FasL. In addition, these results exclude the possibility that the p-coumaric acid-induced apoptosis of Jurkat T cells was initiated by endoplasmic re- (Fig. 6) . However, the IL-2-dependent proliferation of activated T cells was more sensitive to the cytotoxicity of p-coumaric acid than resting T cells and exhibited a viability of 56.8% at a concentration of 150 μM. Under these conditions, the viability of Jurkat T cells (clone A3) was reduced to the level of 99.0%, 88.1%, and 37.3% at concentrations of 50 μM, 100 μM, and 150 μM p-coumaric acid, respectively. These results indicated that malignant leukemia Jurkat T cells, as compared to normal T cells, were more sensitive to the apoptogenic activity of p-coumaric acid.
In conclusion, these results demonstrate that p-coumaric acid, a naturally occurring phenolic acid found in a variety of edible plants including cereals, coffee, fruits, and vegetables, induces apoptotic DNA fragmentation of human acute T cell leukemia Jurkat cells via Bak activation, mitochondrial membrane potential (Δψm) loss, activation of caspase-9, -3, -7, and -8, and resultant cleavage of PARP. Involvement of the extrinsic apoptotic pathway that is triggered by Fas/FasL system in p-coumaric acid-induced apoptosis can be excluded, since the sensitivity of wild-type Jurkat T cell clone A3 to the cytotoxicity of p-coumaric acid is similar to that of FADD-deficient Jurkat T cell clone I2.1 or caspase-8-deficient Jurkat T cells clone I9.2. Current results also indicate that the apoptogenic activity of p-coumaric acid is more potent in malignant Jurkat T cells than in normal human peripheral T cells. These findings will extend our understanding on the potency of p-coumaric acid as an antitumor agent. 4 /well. Each value is expressed as mean±SD (n=3 with three replicates per independent experiment). *p<0.05 compared to control.
